The short version of lyophilization fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2026-06-27 and is reviewed periodically as new material appears.
BPC-157 is a synthetic peptide composed of fifteen amino acid residues, with the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. Its name derives from body protection compound, a term used for a protein fraction identified in human gastric juice. Researchers in Zagreb first reported the pentadecapeptide in the early 1990s and described it as a stable fragment of that larger protein. The compound is also catalogued as PL 14736 and, in some commercial contexts, as bepecin. Its molecular formula is C62H98N16O22 and its monoisotopic mass is approximately 1419 daltons.
Most published work on BPC-157 consists of preclinical studies, including rodent models of tissue injury, gastrointestinal lesions, and vascular or tendon damage, together with in vitro cell assays. Reviews frequently note that the mechanisms proposed in these papers remain incompletely characterised and that findings have not been confirmed in large randomised human trials. The compound is widely sold as a research chemical rather than a licensed medicine, and labels commonly carry a statement that it is not for human use. Whether any of the reported animal effects translate to humans is an open question rather than an established result.
Terminology in the literature is not fully standardised. Papers and product listings use BPC-157, BPC 157, and the longer phrase stable gastric pentadecapeptide BPC 157 interchangeably, and synonyms such as bepecin or PL 14736 appear in older or company-linked publications. Purity claims and reported masses can also differ between sources because peptide preparations may include counterions, residual solvents, or bound water. This variability complicates direct comparison of results across studies and makes the exact identity and grade of a given sample worth verifying. Discussions of the compound should therefore specify the source, salt form, and stated purity where those are known.
Lyophilized peptide powder is generally stored at minus twenty degrees Celsius or lower and kept away from light and moisture. Under these conditions degradation is slow, and sealed vials remain stable for extended periods. Once dissolved, the material is less stable, particularly in aqueous buffers near neutral pH, where hydrolysis and oxidation proceed faster. Solutions are usually kept cold and used within days to weeks. Repeated freeze-thaw cycles are avoided because they encourage aggregation.
Identity and purity are established using reversed-phase high-performance liquid chromatography, which separates the peptide from related impurities and yields a percentage purity. Mass spectrometry, typically with electrospray ionization, confirms the molecular mass against the expected value. Amino acid analysis or peptide mapping provides additional sequence confirmation. These methods are complementary, since chromatography measures how much material is present while mass spectrometry verifies what that material is. A certificate of analysis normally reports both.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C62H98N16O22 | Computed for the free peptide |
| Monoisotopic mass | Approximately 1419 Da | Reported values shift with counterion and hydration |
| Residue count | 15 amino acids | Sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val |
| Origin | Fragment of human gastric juice protein | First described in early 1990s research reports |
| Common synonyms | BPC 157; PL 14736; bepecin | Naming varies across papers and catalogues |
Doses in the literature are usually expressed in micrograms or nanograms per kilogram of body weight. Investigators have administered the peptide by several routes, including injection and oral delivery, depending on the question asked. Route and dose vary widely across studies, which complicates direct comparison of results. Many papers report effects at low doses, but the absence of a standardized protocol limits generalization. Reporting practice differs between research groups.
Some properties, such as the peptide's sequence and molecular mass, are firmly established. Other claims, particularly about mechanism and clinical benefit, remain open questions. Proposed mechanisms include effects on nitric oxide signaling and on cell migration, but these are hypotheses supported by limited evidence. Reviewers often note that the field lacks large controlled human trials. Positive animal findings are best treated as signals for further study rather than as settled conclusions.
Identity and purity are usually assessed by reversed-phase high-performance liquid chromatography with ultraviolet detection near 214 nanometers, a wavelength that captures the peptide backbone. The main peak area is reported as a percentage of total peak area, which serves as a conventional purity figure. Mass spectrometry provides an independent check on molecular mass and helps confirm the expected sequence. Additional tests may include amino acid analysis and water content determination. Results are only comparable when the same column, gradient, and detection settings are used.
Peptides are susceptible to hydrolysis, oxidation, and aggregation, and BPC-157 is no exception. The lyophilized powder form is generally more stable than a solution because residual moisture is low and molecular mobility is reduced. Once dissolved, the peptide is exposed to water, oxygen, and trace metal ions that accelerate degradation. Light exposure and repeated freeze-thaw cycles are also commonly cited as sources of loss. These general principles guide most handling recommendations found in supplier documentation.
Standard practice for the solid form is storage at minus twenty degrees Celsius or colder, kept dry and away from light. Containers are usually sealed with a desiccant to limit moisture uptake. Reconstituted solutions are typically held at two to eight degrees Celsius and used within a short window, because potency can decline over days to weeks depending on the buffer and concentration. Freezing an already dissolved sample may help, though repeated thawing is discouraged. Specific shelf-life claims vary between suppliers and are rarely supported by published stability studies.
Most early work on this peptide originated in the 1990s from a research group in Zagreb, Croatia, relying on animal models and cell cultures. Reported observations included effects on gastrointestinal lesion healing, tendon fibroblast migration, and blood vessel formation under controlled laboratory conditions. These findings come predominantly from rodent studies and in vitro assays rather than from human trials. Controlled human data remain limited, and the degree to which animal results translate to human physiology is an open question rather than a settled fact.
Within the research literature, the peptide is discussed through several provisional mechanisms, including cytoprotection, modulation of growth factor signaling, and interaction with the nitric oxide system. None of these mechanisms is fully characterized, and no single pathway is universally accepted. Review articles typically note the gap between consistent animal findings and sparse human evidence. The compound is classified as a research chemical rather than an approved pharmaceutical, which shapes how studies are designed, funded, and reported.
==== Geochemistry ==== Corals are shallow, colonial organisms that integrate oxygen and trace elements into their skeletal aragonite (polymorph of calcite) crystalline structures as they grow. Geochemical anomalies within the crystalline structures of corals represent functions of temperature, salinity and oxygen isotopic composition. Such geochemical analysis can help with climate modeling. The ratio of oxygen-18 to oxygen-16 (δ18O), for example, is a proxy for temperature.
He moved to the USA and was thereafter active as a senior researcher at the Rockefeller Institute for Medical Research in New York. There, he was the main specialist in protein chemistry and contributed to the great progress of the US in the area of molecular biology. Two eventual Nobel Prize winners (William Howard Stein and Stanford Moore), as well as numerous postdoctoral students (including Klaus H. Hofmann) worked in his laboratory. Bergmann is considered an important figure in synthetic organic chemistry and biochemistry. He specialized in decoding peptide structures, while also researching their synthesis. He died in the Mount Sinai Hospital, New York City, on 7 November 1944. He was elected in 1936 a fellow of the American Association for the Advancement of Science. Since 1980, the Max-Bergmann-Kreis (MBK) company of German peptide chemists awards the Bergmann golden medal for peptide science, with the first medal given to Zervas. In 2002 the Max Bergmann Center was created in Dresden.
{\displaystyle {\frac {\partial W^{*}}{\partial t^{*}}}+U^{*}{\frac {\partial W^{*}}{\partial X^{*}}}+W^{*}{\frac {\partial W^{*}}{\partial Z^{*}}}\ =-{\frac {\partial p_{d}}{\partial Z^{*}}}+Pr\left({\frac {\partial ^{2}W^{*}}{\partial X^{*2}}}+{\frac {\partial ^{2}W^{*}}{\partial Z^{*2}}}\right)\ -{Ra_{s}Pr_{s}S}+{Ra_{T}Pr_{T}T}}
Sources: en.wikipedia.org
In the United Kingdom, the National Union of Rail, Maritime and Transport Workers (RMT) put forward a slate of candidates in the 2009 European Parliament election under the banner of No to EU – Yes to Democracy, a broad left-wing Eurosceptic, alter-globalisation coalition involving socialist groups such as the Socialist Party, aiming to offer a leftist alternative among Eurosceptics to the anti-immigration and pro-business policies of the UK Independence Party. In the subsequent 2010 general election, the Trade Unionist and Socialist Coalition, launched in January 2010 and backed by Bob Crow, the leader of the RMT, along with other union leaders and the Socialist Party among other socialist groups, stood against the Labour Party in forty constituencies. The Trade Unionist and Socialist Coalition contested the 2011 local elections, having gained the endorsement of the RMT June 2010 conference, but it won no seats. Left Unity was also founded in 2013 after the film director Ken Loach appealed for a new party of the left to replace the Labour Party which he claimed had failed to oppose austerity and had shifted towards neoliberalism. Following a second consecutive defeat in the 2015 general election, self-described democratic socialist Jeremy Corbyn succeeded Ed Miliband as the Leader of the Labour Party, leading some to comment that New Labour was "dead and buried." In the 2017 general election, Labour increased its share of the vote to 40% but in the 2019 general election, Labour's vote share fell again.
Sexual medicine is concerned with diagnosing, assessing and treating all disorders related to sexuality. Sports medicine deals with the treatment and prevention and rehabilitation of sports/exercise injuries such as muscle spasms, muscle tears, injuries to ligaments (ligament tears or ruptures) and their repair in athletes, amateur and professional. Therapeutics is the field, more commonly referenced in earlier periods of history, of the various remedies that can be used to treat disease and promote health. Travel medicine or emporiatrics deals with health problems of international travelers or travelers across highly different environments. Tropical medicine deals with the prevention and treatment of tropical diseases. It is studied separately in temperate climates where those diseases are quite unfamiliar to medical practitioners and their local clinical needs. Urgent care focuses on delivery of unscheduled, walk-in care outside of the hospital emergency department for injuries and illnesses that are not severe enough to require care in an emergency department. In some jurisdictions this function is combined with the emergency department. Veterinary medicine; veterinarians apply similar techniques as physicians to the care of non-human animals. Wilderness medicine entails the practice of medicine in the wild, where conventional medical facilities may not be available.
== Pharmacology == Levorphanol acts predominantly as an agonist of the μ-opioid receptor (MOR), but is also an agonist of the δ-opioid receptor (DOR), κ-opioid receptor (KOR), and the nociceptin receptor (NOP), as well as an NMDA receptor antagonist and a serotonin-norepinephrine reuptake inhibitor (SNRI). Levorphanol, similarly to certain other opioids, also acts as a glycine receptor antagonist and GABA receptor antagonist at very high concentrations. As per the World Health Organization, levorphanol is a step 3 opioid and is considered eight times more potent than morphine at the MOR (2 mg levorphanol is equivalent to 15 mg morphine). Relative to morphine, levorphanol lacks complete cross-tolerance and possesses greater intrinsic activity at the MOR. The duration of action is generally long compared to other comparable analgesics and varies from 4 hours to as much as 15 hours. For this reason levorphanol is useful in palliation of chronic pain and similar conditions. Levorphanol has an oral to parenteral effectiveness ratio of 2:1, one of the most favorable of the strong narcotics. Its antagonism of the NMDA receptor, similar to those of the phenylheptylamine open-chain opioids such as methadone or the phenylpiperidine ketobemidone, make levorphanol useful for types of pain that other analgesics may not be as effective against, such as neuropathic pain.
TAB2 in turn serves as a beacon for the recruitment of MEKK1 which then dismisses the N-CoR complex and derepresses its target gene, in effect converting bicalutamide into an AR agonist. This mechanism does not rely on mutations in the LBD of the AR.
Sources: en.wikipedia.org
== Synthetic inorganic chemistry == Although some inorganic species can be obtained in pure form from nature, most are synthesized in chemical plants and in the laboratory. Inorganic synthetic methods can be classified roughly according to the volatility or solubility of the component reactants. Soluble inorganic compounds are prepared using methods of organic synthesis. For metal-containing compounds that are reactive toward air, Schlenk line and glove box techniques are followed. Volatile compounds and gases are manipulated in "vacuum manifolds" consisting of glass piping interconnected through valves, the entirety of which can be evacuated to 0.001 mm Hg or less. Compounds are condensed using liquid nitrogen (b.p. 78 K) or other cryogens. Solids are typically prepared using tube furnaces, the reactants and products being sealed in containers, often made of fused silica (amorphous SiO2) but sometimes more specialized materials such as welded Ta tubes or Pt "boats". Products and reactants are transported between temperature zones to drive reactions.
To ensure that the Presidency of Quito became a part of Gran Colombia and did not remain a collection of small, divided republics, Bolívar sent aid in the form of supplies and an army under Antonio José de Sucre to Guayaquil in February 1821. For a year Sucre was unable to take Quito, and by November both sides, exhausted, signed a ninety-day armistice. The following year, at the Battle of Pichincha on 24 May 1822, Sucre's Venezuelan forces finally conquered Quito; Gran Colombia's hold on the territory was secure. The following year, after a Peruvian Patriot army was destroyed in the Battle of Ica, San Martín met with Simón Bolívar in Guayaquil on 26 and 27 July. Thereafter San Martín decided to retire from the scene. For the next two years, two armies of Rioplatense (Argentinian), Chilean, Colombian and Peruvian Patriots were destroyed trying to penetrate the royalist bastion in the Andean regions of Peru and Upper Peru. A year later a Peruvian congress resolved to make Bolívar head of the Patriot forces in the country. An internecine conflict between La Serna and General Pedro Antonio Olañeta, which was an extension of the Liberal Triennium, proved to be the royalists' undoing. La Serna lost control of half of his best army by the beginning of 1824, giving the Patriots an opportunity.
Most Pakistanis, according to a Pew Research Center (PEW) poll, favour Sharia law as the official law, and 94 percent of them identify more with religion than nationality compared to Muslims in other nations.
After extensive testing, which can take up to six years, the new medicine is ready for marketing and selling. Because of these long timescales and the fact that only one out of every 5000 potential new medicines will ever reach the open market, this is an expensive way of doing things, often costing over 1 USD billion per drug. To recoup this outlay, pharmaceutical companies may do a number of things:
== See also == mRNA, the nucleic acid messenger that serves as the middleman in the Central Dogma of Biology Ribosome, the molecular machine responsible for protein synthesis Translation, the process of peptide synthesis
Sources: en.wikipedia.org
BPC-157 is a synthetic fifteen-amino-acid peptide whose sequence corresponds to a fragment of a protein found in human gastric juice. It is studied mainly in preclinical research and is not an approved pharmaceutical product in major markets. Materials sold for laboratory use are typically labelled as research chemicals.
No medicines regulator in the United States or the European Union has approved BPC-157 as a therapeutic product. Presenting it as a drug or as a dietary supplement ingredient would generally not match its regulatory status. Availability as a research chemical does not imply clinical approval.
Published reports rest largely on animal models and cell culture rather than controlled human trials. Review articles describe the proposed mechanisms as incompletely understood. Conclusions about effects in humans therefore remain tentative.
Bacteriostatic water or sterile saline is commonly used to dissolve the powder. The choice of solvent affects stability and preservation. Aqueous solutions are kept refrigerated and are not intended for long-term storage.